Cargando…

Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study

Micafungin, a clinically important echinocandin antifungal drug, needs to be investigated as empirical therapy in febrile neutropenia in comparison with azole compounds. A prospective randomized study was conducted to compare clinical outcomes between micafungin and intravenous itraconazole as an em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Seong Hyun, Kim, Dae Young, Jang, Jun Ho, Mun, Yeung-Chul, Choi, Chul Won, Kim, Sung-Hyun, Kim, Jin Seok, Park, Joon Seong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710659/ https://www.ncbi.nlm.nih.gov/pubmed/26596974 http://dx.doi.org/10.1007/s00277-015-2545-2

Ejemplares similares

Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
por: Park, Sun Hee, et al.
Publicado: (2006)

Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study
por: Shalhoub, Sarah, et al.
Publicado: (2014)

Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea
por: Kim, Jin Seok, et al.
Publicado: (2014)

Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea
por: Kim, Soo-Jeong, et al.
Publicado: (2014)

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China
por: Yuan, Wei, et al.
Publicado: (2016)

Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan
por: Koh, Hideo, et al.
Publicado: (2013)

Increase in Antibiotic-Resistant Gram-Negative Bacterial Infections in Febrile Neutropenic Children
por: Lee, Joon Hee, et al.
Publicado: (2016)

Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients
por: Libuit, Jessica, et al.
Publicado: (2014)

Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever
por: Yoshida, Isao, et al.
Publicado: (2020)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)

Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Association between cytokine concentration kinetics and prolonged fever in febrile neutropenic children with bacteremia
por: Kim, Seong Koo, et al.
Publicado: (2022)

Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study
por: Kim, Hyo Sup, et al.
Publicado: (2017)

The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
por: Çalık, Şebnem, et al.
Publicado: (2018)

Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes
por: Raheja, Ronak, et al.
Publicado: (2023)

Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients
por: Tuil, O, et al.
Publicado: (2003)

Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
por: Chong, Yong, et al.
Publicado: (2013)

Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea
por: Lee, Dong-Gun, et al.
Publicado: (2011)

Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia
por: Fung, Monica, et al.
Publicado: (2015)

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)

Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and P. aeruginosa
por: Cojutti, Pier Giorgio, et al.
Publicado: (2020)

Distinct Inflammatory Mediator Patterns Characterize Infectious and Sterile Systemic Inflammation in Febrile Neutropenic Hematology Patients
por: Wennerås, Christine, et al.
Publicado: (2014)

466 Skin lesions in febrile neutropenic patients
por: Yemisen, Mucahit, et al.
Publicado: (2014)

The Value of Nasal and Oral Clinical Examination in Febrile Neutropenic Patients for Initiating Antifungal Therapy as a Preemptive Method
por: Salehi, Mohammadreza, et al.
Publicado: (2022)

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
por: Jeon, Youngwoo, et al.
Publicado: (2023)

Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients
por: Garcia-Vidal, Carolina, et al.
Publicado: (2021)

Augmented Renal Clearance and Hypoalbuminemia-Induced Low Vancomycin Trough Concentrations in Febrile Neutropenic Patients With Hematological Malignancies
por: Alzahrani, Abdullah M, et al.
Publicado: (2022)

The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients: A decision analytic model
por: Tori, Katerina, et al.
Publicado: (2020)

The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients
por: Alrstom, Ali, et al.
Publicado: (2021)

Risk factors for neutropenic fever in non- Hodgkin’s lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis
por: Kim, Yu Ri, et al.
Publicado: (2021)

Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
por: Keck, J. Myles, et al.
Publicado: (2023)

Antiviral activity of micafungin against enterovirus 71
por: Kim, Chonsaeng, et al.
Publicado: (2016)

Food-borne bacteremic illnesses in febrile neutropenic children
por: Lee, Anselm Chi-wai, et al.
Publicado: (2011)

Respiratory Viruses in Febrile Neutropenic Patients with Respiratory Symptoms
por: Meidani, Mohsen, et al.
Publicado: (2018)

Candidemia in Febrile Neutropenic Patients; a Brief Report
por: Yousefi, Maysam, et al.
Publicado: (2018)

Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies
por: Jansen, Rogier R, et al.
Publicado: (2013)

Repurposing antifungals: population pharmacokinetics of itraconazole and hydroxy-itraconazole following administration of a nanocrystal formulation
por: Jansen, Anouk M E, et al.
Publicado: (2023)

A Comparative Study of Piperacillin-Tazobactam With and Without Vancomycin as Empirical Therapy for Febrile Neutropenic Patients With Solid Tumor Malignancies
por: Sirkhazi, Mansoor, et al.
Publicado: (2015)

Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis
por: Chen, Ken, et al.
Publicado: (2017)

Identification of Potentially Unnecessary Micafungin Use Patterns: Opportunities for Antifungal Stewardship Interventions
por: Concha, Miguel Chavez, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ekl75jhovbojrkbrh5d014smbe